跳转至内容
Merck
CN

SML0560

Sigma-Aldrich

BRACO19 盐酸盐

≥96% (HPLC), powder, telomerase inhibitor

别名:

N,N′-(9-(4-(二甲氨基)苯氨基)吖啶-3,6-二基)双(3-(吡咯烷-1-基)丙酰胺) 盐酸盐

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C35H43N7O2 · xHCl
分子量:
593.76 (free base basis)
MDL编号:
UNSPSC代码:
12352200
PubChem化学物质编号:
NACRES:
NA.77

产品名称

BRACO19 盐酸盐, ≥96% (HPLC)

质量水平

方案

≥96% (HPLC)

表单

powder

储存条件

desiccated

颜色

yellow to brown

溶解性

H2O: 5 mg/mL, clear

储存温度

2-8°C

SMILES字符串

Cl.Cl.Cl.CN(C)c1ccc(Nc2c3ccc(NC(=O)CCN4CCCC4)cc3nc5cc(NC(=O)CCN6CCCC6)ccc25)cc1

InChI

1S/C35H43N7O2.3ClH/c1-40(2)28-11-7-25(8-12-28)38-35-29-13-9-26(36-33(43)15-21-41-17-3-4-18-41)23-31(29)39-32-24-27(10-14-30(32)35)37-34(44)16-22-42-19-5-6-20-42;;;/h7-14,23-24H,3-6,15-22H2,1-2H3,(H,36,43)(H,37,44)(H,38,39);3*1H

InChI key

MJAPNWJRLLDPAB-UHFFFAOYSA-N

应用

BRACO19 盐酸盐已被用于研究 G4 稳定剂在潜伏人类免疫缺陷病毒-1 (HIV-1) 感染的细胞中抗病毒活性的作用。

生化/生理作用

BRACO19 是一种端粒酶抑制剂,可稳定 G-四链体,靶向端粒 G-四链体,诱导 DNA 损伤和细胞周期阻滞。
BRACO19 稳定 G-四链体;端粒酶抑制剂。
端粒酶与肿瘤进展相关,在编号肿瘤中高表达。已知 BRACO19 可阻止端粒酶的封端和催化操作,因此,可作为癌症治疗的有效治疗方法。BRACO19 确立了对 HIV(人类免疫缺陷病毒)的抗病毒活性。

象形图

Skull and crossbones

警示用语:

Danger

危险声明

危险分类

Acute Tox. 3 Oral

储存分类代码

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Deficiency in DNA damage response, a new characteristic of cells infected with latent HIV-1.
Piekna-Przybylska D, et al.
Cell Cycle, 16(10), 968-978 (2017)
Yu-Lun Chen et al.
The Chinese journal of physiology, 59(6), 331-347 (2016-11-07)
Lung resistance-related protein (LRP) is a human major vault protein (MVP) implicated in drug resistance of cancer cells in a cell-type dependent manner. The primary goal of the study was to understand the role(s) of LRP in doxorubicin (DOX) resistance
The G-quadruplex-interactive molecule BRACO-19 inhibits tumor growth, consistent with telomere targeting and interference with telomerase function.
Burger A M, et al.
Cancer Research, 65(4), 1489-1496 (2005)
Anti-HIV-1 activity of the G-quadruplex ligand BRACO-19.
Perrone R, et al.
The Journal of Antimicrobial Chemotherapy, 69(12), 3248-3258 (2014)
Shyam Sushama Jose et al.
Frontiers in genetics, 9, 345-345 (2018-09-14)
Telomeropathies are rare disorders associated with impaired telomere length control mechanisms that frequently result from genetic mutations in the telomerase complex. Dyskeratosis congenita is a congenital progressive telomeropathy in which mutation in the telomerase RNA component (TERC) impairs telomere maintenance

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门